iDAP injection for Parkinson's disease
Part of Brain & nervous system clinical trials.
This trial tests an injection called iDAP for people with Parkinson's disease. It aims to see if it can improve movement symptoms. You may be able to join if you are between 45 and 75 years old and have had Parkinson's for 4 to 20 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 75 years old.
- You have been diagnosed with Parkinson's disease by a doctor.
- You have had Parkinson's for 4 to 20 years.
- Your Parkinson's is at stage 2 to 4 on the Hoehn and Yahr scale.
- You have been on a stable dose of your Parkinson's medication for at least 3 months.
- You have not had brain surgery, stem cell therapy, or certain other serious conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.
This trial tests whether implanting your own stem cells (made into dopamine-producing brain cells) can improve Parkinson's motor symptoms. You would need to be a candidate for brain surgery and have a stable medication routine.
This early-stage trial tests a new treatment where specialized cells are injected directly into the brain. It is for people with advanced Parkinson's who have been on levodopa for a while and experience 'off' periods or involuntary movements.
This study tests a new treatment for Parkinson's disease where special cells are injected directly into the brain. It aims to reduce 'off' time and improve movement control for people who have had Parkinson's for over 5 years and take levodopa but still experience daily complications.
This early-stage trial tests a new stem cell treatment called NCR201 for people with Parkinson's. It aims to see if the treatment is safe and might help improve symptoms.
This trial tests a new treatment made from your own cells to replace damaged brain cells, aiming to improve movement and reduce symptoms. It's for people who have had Parkinson's for at least 4 years and respond well to levodopa.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.